Result of General Meeting

RNS Number : 4990H

Feedback PLC

15 November 2018

 

15 November 2018

Feedback plc

Result of General Meeting

Cambridge, 15 November 2018: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), is pleased to announce that all resolutions put to shareholders at the Company's General Meeting held earlier today, were duly passed. 

Accordingly, pursuant to the placing and subscription announced on 25 October 2018, 36,200,000 new ordinary shares of 0.25p each are expected to be admitted to trading on AIM tomorrow, 16 November 2018 ("Admission").

Total Voting Rights

On Admission, the Company will have 373,283,250 ordinary shares of 0.25p in issue, each with one voting right. The Company does not hold any shares in treasury. Therefore, the total number of ordinary shares and voting rights in the Company will be 373,283,250.

From Admission, the above figure of 373,283,250 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:
Feedback plc Alastair Riddell, Executive Chairman Lindsay Melvin, CFO	[phone] [e-mail]
Allenby Capital Limited (Nominated Adviser) David Worlidge / Asha Chotai	[phone]
Peterhouse Capital Limited (Joint Broker) Lucy Williams / Duncan Vasey	[phone]
Stanford Capital Partners Limited (Joint Broker) Patrick Claridge / John Howes Instinctif Partners Rozi Morris/ Deborah Bell/ Phillip Marriage	[phone] [phone] [e-mail]

Notes to editors

About Feedback plc

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer. Feedback Medical works with customers globally from headquarters in the internationally renowned scientific hub of Cambridge, UK. Its proprietary technologies are TexRAD^®, the quantitative texture analysis tool and Cadran, a picture archiving communication system (PACS). For more information, see www.fbk.com

 

END

 

 

ROMGGGCWGUPRGGA